RHOA(Ras homolog family member A)属于Rho GTPase家族,是小G蛋白超家族的重要成员,在细胞骨架重组、细胞迁移、增殖和基因表达调控等过程中发挥核心作用。RHOA通过GTP/GDP结合状态切换来调控下游信号通路,激活状态(GTP结合)可结合效应蛋白如ROCK(Rho-associated kinase)和mDia(哺乳动物Diaphanous相关蛋白),进而调节肌动蛋白应力纤维形成、细胞黏附和收缩。其主要作用位点包括细胞膜和胞质,通过与其他Rho家族成员(如RAC1、CDC42)协同调控细胞极性。RHOA突变(如G17V、L57V)可能导致组成性激活或功能丧失,与多种疾病相关:激活突变促进肿瘤侵袭转移(如胃癌、乳腺癌),而功能缺失突变可能影响心血管发育(如动脉导管未闭)。RHOA过表达会增强细胞迁移能力但抑制细胞周期进程,可能导致纤维化疾病或肿瘤转移;表达降低则破坏细胞连接(如上皮-间质转化受阻),影响胚胎发育(如神经嵴细胞迁移异常)。该基因与弥漫性大B细胞淋巴瘤(DLBCL)关系密切,约20%病例存在RHOA p.D120N突变。RHOA属于Rho基因家族(含20多个成员),家族共性为:均含GTP酶结构域,通过GTP水解循环调控细胞形态和运动;共享GEF(鸟苷酸交换因子)/GAP(GTP酶激活蛋白)调控系统;参与整合生长因子和黏附信号。在免疫系统中,RHOA还调控T细胞受体信号转导,其表达异常可能导致自身免疫疾病。最新研究发现RHOA在机械信号转导中起核心作用,能感知细胞外基质硬度并调控YAP/TAZ通路。药物开发中,针对RHOA-ROCK通路的抑制剂(如法舒地尔)已用于治疗脑血管痉挛和肺动脉高压。
无
RHOA基因(以及对应的蛋白质)的细胞分布位置:
RHOA基因的本体(GO)信息:
| 名称 |
|---|
| 4014 Ras signaling pathway [PATH:hsa04014] |
| 4015 Rap1 signaling pathway [PATH:hsa04015] |
| 4310 Wnt signaling pathway [PATH:hsa04310] |
| 4350 TGF-beta signaling pathway [PATH:hsa04350] |
| 4071 Sphingolipid signaling pathway [PATH:hsa04071] |
| 4024 cAMP signaling pathway [PATH:hsa04024] |
| 4022 cGMP - PKG signaling pathway [PATH:hsa04022] |
| 4144 Endocytosis [PATH:hsa04144] |
| 4810 Regulation of actin cytoskeleton [PATH:hsa04810] |
| 4510 Focal adhesion [PATH:hsa04510] |
| 4520 Adherens junction [PATH:hsa04520] |
| 4530 Tight junction [PATH:hsa04530] |
| 4611 Platelet activation [PATH:hsa04611] |
| 4660 T cell receptor signaling pathway [PATH:hsa04660] |
| 4670 Leukocyte transendothelial migration [PATH:hsa04670] |
| 4062 Chemokine signaling pathway [PATH:hsa04062] |
| 4921 Oxytocin signaling pathway [PATH:hsa04921] |
| 4270 Vascular smooth muscle contraction [PATH:hsa04270] |
| 4972 Pancreatic secretion [PATH:hsa04972] |
| 4722 Neurotrophin signaling pathway [PATH:hsa04722] |
| 4360 Axon guidance [PATH:hsa04360] |
| 5200 Pathways in cancer [PATH:hsa05200] |
| 5206 MicroRNAs in cancer [PATH:hsa05206] |
| 5205 Proteoglycans in cancer [PATH:hsa05205] |
| 5203 Viral carcinogenesis [PATH:hsa05203] |
| 5210 Colorectal cancer [PATH:hsa05210] |
| 5130 Pathogenic Escherichia coli infection [PATH:hsa05130] |
| 5133 Pertussis [PATH:hsa05133] |
| 5152 Tuberculosis [PATH:hsa05152] |
| 5100 Bacterial invasion of epithelial cells [PATH:hsa05100] |
| 名称 |
|---|
| Axon guidance |
| Axonal growth inhibition (RHOA activation) |
| Axonal growth stimulation |
| beta-catenin independent WNT signaling |
| Developmental Biology |
| EPH-Ephrin signaling |
| EPHA-mediated growth cone collapse |
| EPHB-mediated forward signaling |
| G alpha (12/13) signalling events |
| G beta:gamma signalling through PI3Kgamma |
| G-protein beta:gamma signalling |
| GPCR downstream signaling |
| GPVI-mediated activation cascade |
| Hemostasis |
| NGF signalling via TRKA from the plasma membrane |
| p75 NTR receptor-mediated signalling |
| p75NTR regulates axonogenesis |
| PCP/CE pathway |
| PI3K/AKT activation |
| Platelet activation, signaling and aggregation |
| Rho GTPase cycle |
| RHO GTPase Effectors |
| RHO GTPases activate CIT |
| RHO GTPases Activate Formins |
| RHO GTPases activate KTN1 |
| RHO GTPases activate PKNs |
| RHO GTPases Activate Rhotekin and Rhophilins |
| RHO GTPases Activate ROCKs |
| Sema4D in semaphorin signaling |
| Sema4D induced cell migration and growth-cone collapse |
| Sema4D mediated inhibition of cell attachment and migration |
| Semaphorin interactions |
| Signaling by GPCR |
| Signaling by Rho GTPases |
| Signaling by TGF-beta Receptor Complex |
| Signaling by VEGF |
| Signaling by Wnt |
| Signalling by NGF |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| VEGFA-VEGFR2 Pathway |
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Stomach Neoplasms | 0.1254487 | 4 | 0 | CTD_human_LHGDN |
| IGA Glomerulonephritis | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
| Angioimmunoblastic Lymphadenopathy | 0.121357209 | 5 | 3 | BeFree_CTD_human |
| Peripheral T-Cell Lymphoma | 0.120814326 | 4 | 3 | BeFree_CTD_human |
| T-Cell Lymphoma | 0.120271442 | 1 | 0 | BeFree_CTD_human |
| Neoplasm Invasiveness | 0.12 | 1 | 0 | CTD_human |
| Lymphoma, T-Cell, Cutaneous | 0.12 | 1 | 0 | CTD_human |
| Proteinuria | 0.12 | 1 | 0 | CTD_human |
| Bladder Neoplasm | 0.12 | 1 | 0 | CTD_human |
| Fibrosis | 0.08272435 | 2 | 0 | LHGDN_RGD |
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269